OBJECTIVES: To perform a head-to-head comparison of four nomograms; namely, the Cagiannos, the 2012-Briganti, the Godoy and the online-Memorial Sloan Kettering Cancer Center (MSKCC), for prediction of lymph node invasion (LNI) in a North American population. PATIENTS AND METHODS: A total of 19 775 patients with clinically localized prostate cancer (PCa) who had undergone radical prostatectomy and pelvic lymph node dissection (PLND) were identified within the Surveillance Epidemiology and End Results (SEER) database. All four nomograms were tested using Heagerty\u27s concordance index (C-index), calibration plots and decision curve analysis (DCA). In addition, we examined specific nomogram-derived thresholds to compare the number of avoided ...
Background: Different nomograms exist for the preoperative prediction of pelvic lymph-node metastati...
Background: Multiple statistical models predicting lymph node involvement (LNI) in prostate cancer (...
Objective: To assess the predictive value of biopsy-identified cribriform carcinoma and/or intraduct...
INTRODUCTION: The aim of our study was to determine the validity of the updated nomogram [Briganti e...
Objective: To validate a nomogram predicting lymph node invasion (LNI) in prostate cancer patients u...
Objectives: to externally validate currently available nomograms for predicting lymph node invasion ...
International audiencePurpose: The Briganti nomogram can be used with a threshold of 5% to decide wh...
OBJECTIVE: To validate a nomogram predicting lymph node invasion (LNI) in prostate cancer patients u...
Objectives To externally validate the currently available nomograms for predicting lymph node invasi...
Background: Few predictive models aimed at predicting the presence of lymph node invasion (LNI) in p...
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoi...
BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend a pelvic lymph node di...
INTRODUCTION: To develop a nomogram to predict lymph node invasion (LNI) in the contemporary North A...
The 2019 Briganti nomogram was developed to calculate the risk of lymph node invasion (LNI) and iden...
Background: Although the therapeutic role of extended pelvic lymph node dissection (ePLND) in patien...
Background: Different nomograms exist for the preoperative prediction of pelvic lymph-node metastati...
Background: Multiple statistical models predicting lymph node involvement (LNI) in prostate cancer (...
Objective: To assess the predictive value of biopsy-identified cribriform carcinoma and/or intraduct...
INTRODUCTION: The aim of our study was to determine the validity of the updated nomogram [Briganti e...
Objective: To validate a nomogram predicting lymph node invasion (LNI) in prostate cancer patients u...
Objectives: to externally validate currently available nomograms for predicting lymph node invasion ...
International audiencePurpose: The Briganti nomogram can be used with a threshold of 5% to decide wh...
OBJECTIVE: To validate a nomogram predicting lymph node invasion (LNI) in prostate cancer patients u...
Objectives To externally validate the currently available nomograms for predicting lymph node invasi...
Background: Few predictive models aimed at predicting the presence of lymph node invasion (LNI) in p...
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoi...
BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend a pelvic lymph node di...
INTRODUCTION: To develop a nomogram to predict lymph node invasion (LNI) in the contemporary North A...
The 2019 Briganti nomogram was developed to calculate the risk of lymph node invasion (LNI) and iden...
Background: Although the therapeutic role of extended pelvic lymph node dissection (ePLND) in patien...
Background: Different nomograms exist for the preoperative prediction of pelvic lymph-node metastati...
Background: Multiple statistical models predicting lymph node involvement (LNI) in prostate cancer (...
Objective: To assess the predictive value of biopsy-identified cribriform carcinoma and/or intraduct...